At a glance
ClinicalIndex Comparison RecordN/ACompleted· 400 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In the news
1 article- FDA assembles vaccine experts to update COVID-19 formulationBioSpace FDA·2026-05-27
Matched to this trial by ClinicalIndexfrom reputable biotech & medical press.
What Happened? Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic
In Brief
An observational study for COVID-19. Completed, enrolled 400 participants across 1 site.
Detailed Summary
Assess the incidence and rates of resistant pathogens prior to and during the COVID-19 pandemic.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJul 2021
First PostedMar 2024
Primary CompletionJul 2025
TodayJul 2026
First PostedMar 28, 2024
Enrollment StartJul 6, 2021
Primary CompletionJul 14, 2025
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 2.3 years ago